X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospectrumasia.com/news/25/22966/japanese-pharma-firm-otsuka-buys-mindset-pharma-for-cad-80-m-to-strengthen-pipeline-in-neurological-disorders.html
https://www.biospace.com/article/releases/otsuka-pharmaceutical-to-acquire-mindset-pharma/?s=61
https://www.europeanpharmaceuticalreview.com/news/184038/uk-trial-to-test-psilocin-based-drug-for-major-depressive-disorder/
https://www.globenewswire.com/news-release/2023/04/26/2654867/0/en/Mindset-Pharma-Files-Two-Patent-Applications-for-its-Non-Hallucinogenic-Non-Tryptamine-Compounds.html
https://www.globenewswire.com/news-release/2023/04/03/2639404/0/en/Mindset-Pharma-to-Participate-in-the-Sequire-Cannabis-Psychedelics-Conference-on-Wednesday-April-5-2023.html
https://www.globenewswire.com/news-release/2023/03/28/2635529/0/en/Mindset-Pharma-CEO-James-Lanthier-Issues-Letter-to-Shareholders-Discussing-Expansion-of-Drug-Discovery-Efforts-into-Novel-Non-Hallucinogenic-Therapeutics.html
https://www.globenewswire.com/news-release/2023/03/14/2626811/0/en/Mindset-Pharma-To-Defend-Against-Lawsuit-Filed-By-Reunion-Neurosciences.html
https://www.globenewswire.com/news-release/2023/03/06/2620922/0/en/Mindset-Pharma-and-PharmAla-Complete-First-Sale-of-Pharmaceutical-Grade-Psilocybin-Into-Growing-Australian-Market-via-Sales-Partnership.html
https://www.globenewswire.com/news-release/2023/02/02/2600328/0/en/Mindset-Pharma-Receives-Another-Allowance-from-USPTO-for-Patent-Application-Expanding-Composition-of-Matter-for-Family-1-Psilocybin-Analogs.html
https://www.globenewswire.com/news-release/2023/01/20/2592383/0/en/Mindset-Pharma-Receives-Allowance-for-U-S-Patent-Application-Covering-Composition-of-Matter-for-Its-Lead-Psychedelic-Therapeutic-Candidate-MSP-1014-And-Additional-Family-1-Tryptami.html
Market Place
Share 
